NewAmsterdam Pharma Co N.V. (NAMS): SCHEDULE 13D/A filed Nov 4, 2025

Form type

SCHEDULE 13D/A

Filing date

Nov 4, 2025

Accession number

0001231919-25-000416

Filer

NewAmsterdam Pharma Co N.V. (CIK 1936258)